1. Advanced cancer
Conditions
Interventions
Patients in both arms of the study participate for 3 months. For patients in the intervention group, physical symptoms will be monitored systematically and treated. Patients in the control group recei
Sponsors
Erasmus MC
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically or cytologically proven solid malignancy; 2. Palliatively aimed treatment; 3. Treatment in the outpatient clinic; 4. Fatigue scored as 4 or higher on a scale of 0 to 10; 5. 18 years or older; 6. WHO performance status of 0,1 or 2; 7. Life expectancy at least months; 8. Able to write and speak Dutch; 9. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Concomitant (or within 4 weeks before randomization) administration of any experimental drug; 2. Untreated depression or anxiety disorders; 3. Severe comorbidity, e.g. heart failure or symptomatic chronic obstructive lung disease; 4. Stay in nursing home; 5. Cognitive limitations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General fatigue at baseline and 1, 2 and 3 months after baseline. Measured with the MFI. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life (EORTC QLQ C30); 2. Multidimensional fatigue (MFI); 3. Daily interference of fatigue (BFI); 4. Anxiety and depression (HADS); 5. Survival. | — |
Contacts
Public ContactP.J. Raaf, de
Erasmus MC Interne Oncologie - kamer G0-03 Antwoordnummer 70780
Outcome results
None listed